Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin vs Paclitaxel in Advanced Breast Cancer
NCT02037529Phase 3Suspended
- Sponsor
- Academic and Community Cancer Research United
- Start
- Jan 2014
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eribulin in breast cancer, sponsored by Academic and Community Cancer Research United. Started Jan 2014; status: suspended.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02037529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02037529.